- Home
- ZYME vs CLB Comparison
ZYME vs CLB Comparison
Compare ZYME & CLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYME
- CLB
- Stock Information
- Founded
- ZYME 2003
- CLB 1936
- Country
- ZYME United States
- CLB United States
- Employees
- ZYME N/A
- CLB N/A
- Industry
- ZYME Biotechnology: Pharmaceutical Preparations
- CLB
- Sector
- ZYME Health Care
- CLB
- Exchange
- ZYME Nasdaq
- CLB Nasdaq
- Market Cap
- ZYME 983.6M
- CLB 841.0M
- IPO Year
- ZYME 2017
- CLB 1995
- Fundamental
- Price
- ZYME $14.39
- CLB $16.13
- Analyst Decision
- ZYME Buy
- CLB Sell
- Analyst Count
- ZYME 6
- CLB 4
- Target Price
- ZYME $19.17
- CLB $17.25
- AVG Volume (30 Days)
- ZYME 340.7K
- CLB 336.7K
- Earning Date
- ZYME 03-05-2025
- CLB 01-29-2025
- Dividend Yield
- ZYME N/A
- CLB 0.25%
- EPS Growth
- ZYME N/A
- CLB N/A
- EPS
- ZYME N/A
- CLB 0.66
- Revenue
- ZYME $62,199,000.00
- CLB $523,847,999.00
- Revenue This Year
- ZYME $21.53
- CLB $6.25
- Revenue Next Year
- ZYME N/A
- CLB $1.78
- P/E Ratio
- ZYME N/A
- CLB $24.45
- Revenue Growth
- ZYME N/A
- CLB 2.76
- 52 Week Low
- ZYME $7.97
- CLB $14.09
- 52 Week High
- ZYME $17.70
- CLB $25.13
- Technical
- Relative Strength Index (RSI)
- ZYME 49.88
- CLB 38.16
- Support Level
- ZYME $14.45
- CLB $16.69
- Resistance Level
- ZYME $15.25
- CLB $18.23
- Average True Range (ATR)
- ZYME 0.73
- CLB 0.76
- MACD
- ZYME -0.02
- CLB -0.06
- Stochastic Oscillator
- ZYME 64.58
- CLB 5.19
About ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated product candidates. Its clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About CLB Core Laboratories Inc.
Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.